Statistical Considerations for Development of Design Space
*Theodora Kourti, GlaxoSmithKline  *Christina Moore, U.S. Food and Drug Administration  *Venkat Sethuraman, Novartis  *Greg Stockdale, GlaxoSmithKline  *Yi Tsong, U.S. Food and Drug Administration 

Keywords: